Aptose Biosciences Inc. (TSX:APS)
Canada · Delayed Price · Currency is CAD 2.360
+0.020 (0.85%)
May 1, 2026, 2:16 PM EST
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of CAD 5.97 million as of May 1, 2026. Its market cap has decreased by -54.47% in one year.
Market Cap
5.97M
Enterprise Value
42.00M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.36
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 47.29M to 5.97M, a decrease of -87.37%. That is a compound annual growth rate of -6.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 5.97M | 10.38% |
| Dec 31, 2025 | 5.41M | -72.33% |
| Dec 31, 2024 | 19.56M | -26.49% |
| Dec 29, 2023 | 26.61M | -63.04% |
| Dec 30, 2022 | 71.99M | -53.23% |
| Dec 31, 2021 | 153.93M | -69.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marvel Biosciences | 10.71M |
| MindBio Therapeutics | 10.49M |
| Glow Lifetech | 8.65M |
| COSCIENS Biopharma | 8.57M |
| PharmaTher Holdings | 7.74M |
| Quest PharmaTech | 6.77M |
| Kane Biotech | 6.36M |
| Restart Life Sciences | 5.94M |